Gut microbiota–derived short-chain fatty acids and kidney diseases
Lingzhi Li(Affiliated Hospital of Southwest Medical University), Ping Fu(Shandong Center for Disease Control and Prevention), Liang Ma(Guangdong Pharmaceutical University)
Cited by 157
Related Papers
Kidney fibrosis: from mechanisms to therapeutic medicines
|Signal Transduction and Targeted Therapy|2023|646
Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
|Acta Diabetologica|2019|183
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
|Cell Metabolism|2020|171
Isolation and characterization of Pseudomonas brassicacearum J12 as an antagonist against Ralstonia solanacearum and identification of its antimicrobial components
|Microbiological Research|2012|110
FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury
|Signal Transduction and Targeted Therapy|2022|106